Prulifloxacin News
Most Popular Prulifloxacin Story
Optimer announces postive Phase II data
Optimer Pharmaceuticals has announced positive Phase III data from a trial of Prulifloxacin for infectious diarrhea. The drug, which is given in a once-daily dose, met the primary endpoint, and had a Read more...
Latest Headlines
- July 16, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
